Eric Pauwels
2020 - PTC Therapeutics
In 2020, Eric Pauwels earned a total compensation of $4.4M as Chief Business Officer at PTC Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $297,700 |
|---|---|
| Option Awards | $2,897,338 |
| Salary | $474,381 |
| Stock Awards | $719,956 |
| Other | $7,618 |
| Total | $4,396,994 |
Pauwels received $2.9M in option awards, accounting for 66% of the total pay in 2020.
Pauwels also received $297.7K in non-equity incentive plan, $474.4K in salary, $720K in stock awards and $7.6K in other compensation.
Rankings
In 2020, Eric Pauwels' compensation ranked 2,576th out of 13,090 executives tracked by ExecPay. In other words, Pauwels earned more than 80.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,576 out of 13,090 | 80th |
Division Manufacturing | 989 out of 5,620 | 82nd |
Major group Chemicals And Allied Products | 362 out of 2,253 | 84th |
Industry group Drugs | 312 out of 1,953 | 84th |
Industry Pharmaceutical Preparations | 228 out of 1,458 | 84th |
Source: SEC filing on April 29, 2021.
Pauwels' colleagues
We found five more compensation records of executives who worked with Eric Pauwels at PTC Therapeutics in 2020.
2020
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
2020
Marcio Souza
PTC Therapeutics
Chief Operating Officer
2020
Neil Almstead
PTC Therapeutics
Chief Technical Operations Officer
2020
Emily Hill
PTC Therapeutics
Chief Financial Officer
2020
Mark Boulding
PTC Therapeutics